Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phlebotomy versus cyproterone compound in women with polycystic ovary syndrome
IRCT2013080514277N1Phase 3Completed
- Sponsor
- Research Institute for Endocrine Sciences
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyproterone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Research Institute for Endocrine Sciences. Primary endpoints: Hirsutism score and HOMA-IR score. Started Jun 2014; status: completed.
02
Drugs
cyproterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT2013080514277N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013080514277N1.